mb-1 vs glp-1 GLP-1-based therapies for diabetes, obesity and beyond formulated to aid in metabolic health Glucagon-like peptide-1 receptor agonists and

Description

This is particularly important if you take insulin or sulfonylureas Monitor for worsening gastrointestinal symptoms, especially during Wegovy dose escalation Keep a symptom diary to identify any new or worsening side effects If you have diabetes, you may need more frequent blood glucose monitoring When to seek immediate medical advice: Severe or persistent abdominal pain (potential pancreatitis) Signs of hypoglycaemia that do not resolve with usual measures Severe nausea, vomiting, or diarrhoea leading to dehydration Allergic reactions (rash, swelling, difficulty breathing) Any unexplained symptoms after starting the combination For urgent concerns, contact NHS 111 or 999 in an emergency

In Australia, report concerns to the TGA for safety tracking

Recent studies suggest that GLP-1R agonists may influence the neurovascular unit (NVU), the critical interface where neurons, glial cells, and blood vessels interact to maintain brain function

Maybe you get tired, burpy, bloated, refluxy, or afraid to eat the wrong thing

The Ozempic lawsuit refers to a growing number of product liability claims filed against drug manufacturers Novo Nordisk and Eli Lilly alleging that GLP-1 medications caused severe injuries that were not adequately disclosed to patients or prescribing physicians